We examined the percentage of CD8+Foxp3+ Tcregs from PBMCs and freshly isolated TILs of NPC patients by analyzing the expression of CD8 and Foxp3 (Figure 1). The gene discussed is CD8A; the disease is nasopharyngeal carcinoma.